Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Genital Diseases, Male × apalutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 52 Neoplasm Metastasis 2 Stage II Prostate Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Salivary Gland Neoplasms 1 Prostate Cancer Metastatic 1 Non-metastatic Castration-resistant Prostate Cancer 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Fatigue 1 Depression 1 Castration Levels of Testosterone 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1 Adenocarcinoma 1

Interventions

gedatolisib 1 gallium 68 PSMA-11 1 darolutamide 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡